Of the two sister angiotensin II receptors, one has become a reliable drug target, while the other has remained something of a puzzle. The reliable one, known as AT1, has inspired many of the hypertension medications currently on the market. The...
BASEL (dpa-AFX) - Ligand Pharmaceuticals Inc. (LGND) said it has entered
into global license and supply agreements with Novartis AG (NVS) for the
development and commercialization of a Captisol-enabled oral liquid formulation
In a letter to the U.S. Senate Special Committee on Aging, the founder and president of the Lantern Foundation urged Senate members to investigate a number of alleged offenses by Ligand Pharmaceuticals Inc. (NASDAQ: LGND).
"After several years...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Ligand Pharmaceuticals (LGND):